22nd Century Group, Inc. Licenses X-22 to Pharmaceutical Subsidiary; New York Times Reports Company Delivers Government Research Cigarettes

Published: Oct 31, 2011

CLARENCE, N.Y.--(BUSINESS WIRE)--22nd Century Group, Inc. (OTCBB: XXII), a company focused on smoking cessation and tobacco harm reduction products, announced today that the company licensed Hercules Pharmaceuticals LLC, its wholly-owned pharmaceutical subsidiary, exclusive worldwide rights to X-22.

Back to news